About Us

At VitaEternia, we are driven by a relentless commitment to advancing healthcare through cutting-edge clinical research. As a leading clinical research company, we specialize in designing and conducting clinical trials that pave the way for groundbreaking medical discoveries. Our unwavering dedication to excellence, innovation, and ethical practices sets us apart as a trusted partner for pharmaceutical and biotechnology companies, academic institutions, and healthcare organizations worldwide.

Founder's Message

At VitaEternia, we are committed to advancing medical science and enhancing patient care through ethical and innovative clinical research. Our mission is to bridge the gap between scientific discovery and patient well-being by delivering high-quality, reliable clinical trial management services. We emphasize collaboration, partnering with sponsors, healthcare institutions, and regulatory bodies to ensure efficient, compliant, and impactful trials.

Our dedicated team drives our success, upholding precision, integrity, and excellence in every project. Focusing on Phase 3, Phase 4, post-marketing, and investigator-initiated studies, we aim to accelerate the delivery of innovative treatments to patients. Thank you for partnering with us to advance healthcare and make a positive impact on patients’ lives worldwide.

Our Mission

To be a trusted global partner in advancing healthcare through innovative, ethical, and high-quality clinical research, accelerating the development of safe and effective treatments that improve patient outcomes and enhance the quality of life worldwide.

Our Vision

Our vision is to be a global leader in clinical research, advancing healthcare with innovation, integrity, and excellence. We focus on delivering groundbreaking medical treatments through efficient management of Phase 3, Phase 4, post-marketing, and investigator-initiated studies. By setting new standards in trial management, patient care, and regulatory compliance, we aim to improve health outcomes and accelerate access to effective therapies. Leveraging cutting-edge technologies and fostering strong partnerships, we are dedicated to driving progress in medical science, enhancing the quality of care, and contributing to better health worldwide.

Works

3

We are already three investigator initiated study old, all of which has been published in esteemed journals

7

Advancing Innovation: 7 Peer-Reviewed Research Papers Published by Our Experts!

600

Patients recruited, followed up, data collected by our site management team from ground zero.

Papers

Response outcome of neo adjuvant chemo therapy and feasibility of breast conservation surgery among locally advanced breast cancer patients: a prospective evaluation

A prospective observational pilot study assessing the outcomes of implementing the eras protocol in colorectal surgery at a national tertiary care hospital

A case control study to establish the efficacy of mid urethral sling (tot) following vaginal prolapse repair in patients without Urinary incontinence

A randomized clinical study comparing Trupler skin stapler and Trulon polyamide suture in post-surgical skin closure during orthopaedic and open abdominal surgeries

Dastidar D G, Sanyal R, Dastidar NG, Halder T, An Outcome Analysis of Asymptomatic COVID-19 Patients with Angina

Ahmed S, Patra S, Manna N, Halder T, A Randomised Clinical Study Comparing Surgipler Skin Stapler and Trulon Polyamide Suture

Ray R, Sarkar R, Gupta S, Halder T, Trushield NXT Non Adherent Wound Dressing versus Standard of Care Dressing, Trushield NXT Non Adherent Wound Dressing versus Standard of Care Dressing